HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiziana Genovese Selected Research

Septic Shock (Toxic Shock Syndrome)

2/2010Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.
10/2006Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
9/2005Melatonin limits lung injury in bleomycin treated mice.
4/2005Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin.
8/2004Methylguanidine reduces the development of non septic shock induced by zymosan in mice.
6/2004Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiziana Genovese Research Topics

Disease

92Inflammation (Inflammations)
06/2023 - 07/2002
38Spinal Cord Injuries (Spinal Cord Injury)
08/2011 - 10/2004
26Edema (Dropsy)
10/2022 - 12/2003
26Shock
09/2020 - 09/2003
23Myelitis
04/2011 - 02/2005
22Necrosis
09/2022 - 07/2002
21Body Weight (Weight, Body)
09/2022 - 11/2003
21Lung Injury
10/2020 - 07/2002
17Colitis
03/2024 - 07/2002
17Pancreatitis
03/2024 - 09/2003
16Ischemia
03/2024 - 04/2004
13Pleurisy (Pleuritis)
01/2024 - 07/2002
12Wounds and Injuries (Trauma)
04/2022 - 02/2005
11Pain (Aches)
06/2023 - 07/2008
11Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2021 - 07/2002
10Fibrosis (Cirrhosis)
09/2022 - 11/2006
10Reperfusion Injury
09/2020 - 09/2003
9Weight Loss (Weight Reduction)
10/2020 - 07/2002
8Pneumonia (Pneumonitis)
06/2023 - 08/2003
8Neuroinflammatory Diseases
12/2022 - 05/2020
8Multiple Organ Failure (MODS)
02/2010 - 11/2003
7Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2023 - 02/2006
7Diarrhea
08/2011 - 07/2002
6Arthritis (Polyarthritis)
10/2022 - 12/2003
6Brain Injuries (Brain Injury)
06/2022 - 02/2011
6Acute Lung Injury
03/2022 - 07/2002
6Hemorrhage
10/2021 - 12/2003
6Septic Shock (Toxic Shock Syndrome)
02/2010 - 06/2004
5Experimental Arthritis
10/2022 - 12/2003
4Parkinson Disease (Parkinson's Disease)
04/2024 - 06/2020
4Endometriosis
05/2022 - 04/2021
4Hypoxia (Hypoxemia)
04/2009 - 12/2004
3Infarction (Infarctions)
05/2023 - 02/2011
3Hyperalgesia
05/2022 - 05/2020
3Atherosclerosis
04/2022 - 02/2010

Drug/Important Bio-Agent (IBA)

373-nitrotyrosineIBA
10/2011 - 12/2003
33Peroxidase (Myeloperoxidase)IBA
08/2021 - 09/2003
27CytokinesIBA
06/2023 - 07/2002
26Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 09/2003
21NF-kappa B (NF-kB)IBA
06/2023 - 11/2003
19LigandsIBA
01/2024 - 09/2003
18Bleomycin (Blenoxane)FDA LinkGeneric
06/2023 - 05/2005
17CarrageenanIBA
01/2024 - 07/2002
17ZymosanIBA
02/2010 - 11/2003
16CeruletideIBA
03/2024 - 09/2003
16AntioxidantsIBA
10/2022 - 10/2005
14DinitrobenzenesIBA
03/2021 - 07/2002
13Sulfonic AcidsIBA
03/2021 - 07/2002
13Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2011 - 09/2003
122,4-dinitrofluorobenzene sulfonic acidIBA
03/2021 - 04/2004
12AmylasesFDA Link
08/2020 - 09/2003
12Lipase (Acid Lipase)FDA Link
08/2020 - 09/2003
12Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2011 - 03/2004
12DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
02/2010 - 02/2005
11EnzymesIBA
04/2022 - 07/2002
11PPAR alphaIBA
12/2009 - 10/2004
9Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2007 - 07/2002
8palmidrolIBA
10/2021 - 07/2008
8Reactive Oxygen Species (Oxygen Radicals)IBA
07/2020 - 01/2004
8Interleukin-1beta (Interleukin 1 beta)IBA
04/2009 - 07/2002
7CollagenIBA
04/2021 - 06/2005
7P-SelectinIBA
08/2020 - 09/2003
7Uridine Triphosphate (UTP)IBA
02/2010 - 02/2005
7Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2009 - 12/2004
7Transcription Factors (Transcription Factor)IBA
12/2009 - 11/2003
7Peroxynitrous Acid (Peroxynitrite)IBA
07/2009 - 03/2005
7PPAR gammaIBA
08/2008 - 09/2003
7DNA (Deoxyribonucleic Acid)IBA
11/2006 - 07/2002
6Poly Adenosine Diphosphate RiboseIBA
02/2010 - 06/2004
6TeaIBA
11/2009 - 05/2005
6MelatoninIBA
08/2009 - 04/2005
6Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
09/2005 - 06/2003
5Collagen Type II (Type II Collagen)IBA
10/2022 - 12/2003
5Dexamethasone (Maxidex)FDA LinkGeneric
06/2021 - 06/2005
5Superoxide DismutaseIBA
03/2020 - 01/2004
5Proteins (Proteins, Gene)FDA Link
06/2013 - 08/2004
5Fas Ligand Protein (Fas Ligand)IBA
02/2010 - 11/2006
5PolyphenolsIBA
11/2009 - 05/2005
5InterleukinsIBA
06/2008 - 09/2003
5Rosiglitazone (Avandia)FDA Link
05/2004 - 09/2003
4Analgesics (Analgesic Drugs)IBA
06/2023 - 05/2020
4Etanercept (Enbrel)FDA Link
05/2022 - 03/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 08/2006
4AcidsIBA
04/2021 - 07/2002
4Malondialdehyde (Propanedial)IBA
07/2020 - 09/2003
4ProstaglandinsIBA
07/2009 - 05/2005
4GlucocorticoidsIBA
05/2009 - 11/2004
4Inflammation MediatorsIBA
09/2008 - 08/2005
4Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2008 - 10/2004
4Transforming Growth Factor beta (TGF-beta)IBA
01/2008 - 08/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2007 - 08/2004
4SuspensionsIBA
11/2006 - 01/2004
45-aminoisoquinolinoneIBA
05/2005 - 05/2004
3Endocrine DisruptorsIBA
04/2024 - 05/2022
3Interleukin-6 (Interleukin 6)IBA
01/2023 - 07/2002
3Nerve Growth Factors (Neurotrophins)IBA
06/2022 - 04/2011

Therapy/Procedure

26Laminectomy
08/2011 - 10/2004
18Therapeutics
01/2023 - 01/2004
14Intraperitoneal Injections
06/2021 - 09/2003
4Injections
10/2022 - 06/2021